JP2002516881A5 - - Google Patents

Download PDF

Info

Publication number
JP2002516881A5
JP2002516881A5 JP2000551814A JP2000551814A JP2002516881A5 JP 2002516881 A5 JP2002516881 A5 JP 2002516881A5 JP 2000551814 A JP2000551814 A JP 2000551814A JP 2000551814 A JP2000551814 A JP 2000551814A JP 2002516881 A5 JP2002516881 A5 JP 2002516881A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000551814A
Other languages
Japanese (ja)
Other versions
JP3727848B2 (ja
JP2002516881A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/010189 external-priority patent/WO1999062560A1/en
Publication of JP2002516881A publication Critical patent/JP2002516881A/ja
Application granted granted Critical
Publication of JP3727848B2 publication Critical patent/JP3727848B2/ja
Publication of JP2002516881A5 publication Critical patent/JP2002516881A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000551814A 1998-06-05 1999-05-10 酸化マグネシウムを使用する、ace阻害剤を含有する組成物の安定化 Expired - Fee Related JP3727848B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8828098P 1998-06-05 1998-06-05
US60/088,280 1998-06-05
PCT/US1999/010189 WO1999062560A1 (en) 1998-06-05 1999-05-10 Stabilization of compositions containing ace inhibitors using magnesium oxide

Publications (3)

Publication Number Publication Date
JP2002516881A JP2002516881A (ja) 2002-06-11
JP3727848B2 JP3727848B2 (ja) 2005-12-21
JP2002516881A5 true JP2002516881A5 (https=) 2005-12-22

Family

ID=22210458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000551814A Expired - Fee Related JP3727848B2 (ja) 1998-06-05 1999-05-10 酸化マグネシウムを使用する、ace阻害剤を含有する組成物の安定化

Country Status (32)

Country Link
US (3) US6417196B1 (https=)
EP (1) EP1083931B1 (https=)
JP (1) JP3727848B2 (https=)
KR (1) KR20010052557A (https=)
CN (1) CN1144598C (https=)
AR (1) AR019150A1 (https=)
AT (1) ATE295184T1 (https=)
AU (1) AU755616B2 (https=)
BR (1) BR9910947A (https=)
CA (1) CA2330581A1 (https=)
CO (1) CO5011043A1 (https=)
DE (1) DE69925269T2 (https=)
ES (1) ES2242398T3 (https=)
GT (1) GT199900079A (https=)
HK (1) HK1038879B (https=)
HN (1) HN1999000088A (https=)
HU (1) HUP0102260A3 (https=)
ID (1) ID27398A (https=)
IL (1) IL139590A0 (https=)
IS (1) IS2270B (https=)
MY (1) MY119667A (https=)
NO (1) NO20006148D0 (https=)
NZ (1) NZ508544A (https=)
PA (1) PA8475001A1 (https=)
PE (1) PE20000543A1 (https=)
PL (1) PL344586A1 (https=)
SV (1) SV1999000072A (https=)
TR (1) TR200003600T2 (https=)
TW (1) TW565455B (https=)
UY (1) UY25546A1 (https=)
WO (1) WO1999062560A1 (https=)
ZA (1) ZA200006537B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062560A1 (en) * 1998-06-05 1999-12-09 Warner-Lambert Company Stabilization of compositions containing ace inhibitors using magnesium oxide
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
CA2408796C (en) * 2000-05-24 2009-12-15 Otsuka Pharmaceutical Co., Ltd. Method of stabilizing preparation
UA78542C2 (en) * 2002-01-15 2007-04-10 Actavis Group Hf Formulations of quinapril and other ace inhibitors
US20030157165A1 (en) * 2002-02-01 2003-08-21 Sherman Bernard Charles Stable saccharide-free tablets comprising a salt of quinapril or moexipril
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
CZ298224B6 (cs) * 2003-04-29 2007-07-25 Pliva Istrazivanje I Razvoj D.O.O. Farmaceutická kompozice obsahující jako úcinnou látku ribavirin a zpusob její výroby
WO2005002548A1 (en) * 2003-06-26 2005-01-13 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
WO2006016530A1 (ja) * 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
US20060141054A1 (en) * 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
ITMI20060026A1 (it) * 2006-01-10 2007-07-11 Truffini & Regge Farmaceutici Srl Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
US20070232680A1 (en) * 2006-04-04 2007-10-04 Vijayabhaskar Bolugoddu Preparation of ramipril and stable pharmaceutical compositions
US20080015188A1 (en) * 2006-04-19 2008-01-17 Julia Hrakovsky Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives
CA2653382A1 (en) * 2006-06-30 2008-01-03 Alphapharm Pty Ltd A stabilised composition comprising ace inhibitors
US20080071141A1 (en) * 2006-09-18 2008-03-20 Abhisuek Gattani Method and apparatus for measuring attributes of an anatomical feature during a medical procedure
US8337817B2 (en) * 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
WO2008132756A1 (en) * 2007-05-01 2008-11-06 Lupin Limited Stable pharmaceutical compositions of ramipril
JP5113476B2 (ja) * 2007-10-09 2013-01-09 沢井製薬株式会社 保存安定性に優れた塩酸テモカプリルの錠剤
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
TR200906322A2 (tr) 2009-08-17 2011-07-21 Bi̇lgi̇ç Mahmut Çözünürlük ve stabilite özellikleri geliştirilmiş granüller.
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
TN2010000566A1 (en) * 2010-12-03 2012-05-24 Rekik Raouf Folic acid - ramipril combination : cell protective neuroprotective and retinoprotective ophtalmologic drugs
CN102512656B (zh) * 2011-12-27 2013-11-27 天津市嵩锐医药科技有限公司 盐酸喹那普利药物组合物
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320029A (en) 1967-05-16 Method of preparing magnesia
IL58849A (en) 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4425355A (en) 1981-02-17 1984-01-10 Warner-Lambert Company Substituted acyl derivatives of chair form of octahydro-1H-indole-2-carboxylic acids
US4793998A (en) 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4830583A (en) * 1988-03-02 1989-05-16 Sri International Fluid motor-pumping apparatus and system
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
HU222489B1 (hu) * 1990-07-25 2003-07-28 Novartis Ag. Stabilizált gyógyszerkészítmények és eljárás az előállításukra
IT1251153B (it) * 1991-08-06 1995-05-04 Vectorpharma Int Composizioni farmaceutiche solide per somministrazione orale aventi proungata residenza gastrica
JP3414539B2 (ja) * 1994-05-11 2003-06-09 有限会社ドット 経鼻吸収用組成物
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
WO1999062560A1 (en) * 1998-06-05 1999-12-09 Warner-Lambert Company Stabilization of compositions containing ace inhibitors using magnesium oxide
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor

Similar Documents

Publication Publication Date Title
BE2018C020I2 (https=)
BE2015C057I2 (https=)
BE2016C007I2 (https=)
BE2015C018I2 (https=)
BE2014C017I2 (https=)
BE2013C051I2 (https=)
BE2013C020I2 (https=)
BE2013C015I2 (https=)
BE2013C001I2 (https=)
BE2012C036I2 (https=)
BE2008C046I2 (https=)
BE1025464I2 (https=)
BE2010C011I2 (https=)
BRPI0017527B8 (https=)
BE2008C047I2 (https=)
BE2011C004I2 (https=)
BRPI0001672A2 (https=)
BRPI0001542A2 (https=)
BRPI0012675B8 (https=)
BRPI0017522A2 (https=)
BRMU7902607U2 (https=)
BRPI9917761A2 (https=)
BRPI0303609A (https=)
CN3097470S (https=)
CN3097510S (https=)